Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07205120) titled 'Fluid Guided Heart Failure Treatment at the Cleveland Clinic' on Sept. 24.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Bodyport Inc.

Condition: Heart Failure

Intervention: Device: Heart Failure Management Intervention

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: October 2025

Target Sample Size: 50

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07205120

Published by HT Digital Content Services wit...